ESSENTIAL OIL MANUFACTURING BUSINESS PLAN

I. Executive Summary

Company Description

The company has no disclosed name. It is a United States–based manufacturer launching in 2026 that produces 100% pure, therapeutic-grade essential oils under a "Source-to-Scent" model that emphasizes radical transparency and scientific verification. The business operates in the natural wellness and personal care sector and serves two primary markets: individual wellness consumers and B2B buyers in the spa and cosmetic industries. One-liner: launching in 2026 to supply verified, pure therapeutic oils to consumers and spas.

The company controls sourcing, in-house distillation, and third-party verified testing to guarantee product integrity and sustainability. Core activities include sustainable raw-material procurement, advanced steam and cold distillation, batch-level laboratory verification, packaging, and B2B account management for spas and cosmetic formulators. Short-term goals: commence production in 2026 and validate quality with third-party tests. Long-term goals: scale B2B contracts, broaden retail distribution, and maintain traceable supply chains. One-liner: vertically integrated production and verified testing create a clear quality advantage for two market segments.

Problem

The domestic wellness market lacks reliable verification of botanical origin and chemical composition for many essential oils, creating a clear trust gap. Buyers—individual consumers and small-to-medium wellness businesses—face inconsistent raw materials, failed purity claims, time lost chasing lab results, and regulatory and liability exposure.

Buyers need verifiable, therapeutically consistent essential oils from a transparent manufacturer.

Solution

We manufacture 100% pure, therapeutic-grade essential oils in the U.S. using state-of-the-art distillation technology and full control of the value chain—from sustainable botanical sourcing to final bottling—to solve a market plagued by low-quality, adulterated products and opaque sourcing. All oils undergo rigorous third-party testing and come with batch-specific documentation, serving aromatherapists with certified single-origin oils and cosmetic formulators with verifiable batch-quality reports.

Every batch is testable and traceable, providing direct access to lab reports and a guarantee of 100% unadulterated purity.

Mission Statement

We restore trust in the botanical industry by producing 100% pure, scientifically verified essential oils with radical transparency from harvest to bottle. We commit to sustainable sourcing, U.S.-based manufacturing excellence, and providing customers and professionals with the data they need to use oils safely and effectively. Our goal is to lead the market in Source-to-Scent integrity, ensuring every drop is as pure as nature intended.

Key Success Factors

Five measurable operational and financial milestones will determine early success.

• Batch-code transparency system adoption: successful implementation and customer uptake.
• Long-term farm partnerships: stable supply of high-quality sustainable botanicals.
• 2026 production target: achieve 27,500 total units to establish market momentum.
• CapEx stewardship: efficient management of the $545,000 distillation and testing investment.
• Breakeven timing: reach breakeven in February 2027 to validate the model.

Financial Summary

Brief financial snapshot: launch in 2026, breakeven in Feb-2027, and scaled profitability by 2030.

The business requires a minimum cash buffer of $766,000 (min cash month: Feb-2027); breakeven is expected in Feb-2027 (14 months), with a payback period of 39 months and an ROE of 3.25%.

Overall outlook: modest near-term returns and rapid EBITDA growth through 2028.

Funding Requirements

The company will launch in 2026 and requires $1,311,000 to buy equipment, stock inventory, and carry cash to the projected breakeven in Feb-2027 (14 months), with Year 1 EBITDA of $6,000 scaling to $1,545,000 by 2030 and production rising from 27,500 to 87,000 units.